Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia

European Journal of Epidemiology

Volumn 27, Issue 5, 2012, Pages 341-347

  Krämer, Heike Ursula ^a   Müller, Heiko ^a   Stegmaier, Christa ^b   Rothenbacher, Dietrich ^a,c   Raum, Elke ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Epidemiological Cancer Registry of Saarland   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Cohort study; Colorectal cancer; Gender; Neoplasm; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX DIFFERENCE;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 84863719840     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9686-6     Document Type: Article

References (33)

1. GLOBOCAN. Colorectal cancer incidence and mortality worldwide in 2008. Summary [updated 2008; cited 06/07/2010]. Available from: http://globocan.iarc. fr/factsheets/cancers/colorectal. asp. 2008.
2. Hoffmeister M, Chang-Claude J, Brenner H. Do older adults using NSAIDs have a reduced risk of colorectal cancer? Drugs Aging. 2006;23(6):513-23.
3. AICR. World cancer research fund /American Institute for cancer research. Washington, DC: Food, nutrition, physical activity and the prevention of cancer: A global perspective; 2007.
4. Hoffmeister M, Raum E, Krtschil A, et al. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clin Pharmacol Ther. 2009; 86(4):416-24.
5. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3(8):687-95.
6. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6(2):164-79.
7. Chodick G, Heymann AD, Rosenmann L, et al. Diabetes and risk of incident cancer: A large population-based cohort study in Israel. Cancer Causes Control. 2010;21(6):879-87.
8. He J, Stram DO, Kolonel LN, et al. The association of diabetes with colorectal cancer risk: The Multiethnic Cohort. Br J Cancer. 2010;103(1):120-6.
9. Khaw KT, Wareham N, Bingham S, et al. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: A prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004;13(6):915-9.
10. Levi F, Pasche C, Lucchini F, et al. Diabetes mellitus, family history, and colorectal cancer. J Epidemiol Community Health. 2002;56(6):479-80.
11. Lund Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417-22.
12. Sandhu MS, Luben R, Khaw KT. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: Population based, cross sectional study. J Epidemiol Community Health. 2001;55(11):804-5.
13. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care. 2005;28(7):1805-7.
14. Stürmer T, Buring JE, Lee IM, et al. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2391-7.
15. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91(6):542-7.
16. Limburg PJ, AndersonKE, JohnsonTW, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the IowaWomen's Health Study. Cancer Epidemiol Biomarkers Prev. 2005;14(1):133-7.
17. Flood A, Strayer L, Schairer C, et al. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010.
18. Siddiqui AA, Maddur H, Naik S, et al. The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus. Dig Dis Sci. 2008;53(4):1042-7.
19. Elwing JE, Gao F, Davidson NO, et al. Type 2 diabetes mellitus: The impact on colorectal adenoma risk in women. Am J Gastroenterol. 2006;101(8):1866-71.
20. Marugame T, Lee K, Eguchi H, et al. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control. 2002;13(10):917-21.
21. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3): 199-200.
22. Ashbeck EL, Jacobs ET, Martinez ME, et al. Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1134-43.
23. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: A meta-Analysis. J Natl Cancer Inst. 2005; 97(22):1679-87.
24. Campbell PT, Deka A, Jacobs EJ, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010;139(4):1138-46.
25. Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009; 5(10):553-8.
26. Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: A cross-sectional, case-control study. Am J Gastroenterol. 2010;105(1): 178-87.
27. Yamamoto S, Nakagawa T, Matsushita Y, et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care. 2010;33(1):184-9.
28. Yamaji T, Iwasaki M, Sasazuki S, et al. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res. 2010;70(13):5430-7.
29. Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med 2008; 65(7): 481 (501-486).
30. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1688-94.
31. Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: A case-control study in Korea. Dig Liver Dis. 2006;38(9):668-72.
32. Luchtenborg M, White KK, Wilkens L, et al. Smoking and colorectal cancer: Different effects by type of cigarettes? Cancer Epidemiol Biomarkers Prev. 2007;16(7):1341-7.
33. Johns LE, Houlston RS. A systematic review and meta-Analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001; 96(10):2992-3003.